SARS-COV 2
Clinical trials for SARS-COV 2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV 2 trials appear
Sign up with your email to follow new studies for SARS-COV 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Massive study tracks 12,000 people for COVID vaccine side effects
⭐️ VACCINE ⭐️ OngoingThis study is monitoring the safety of the already-approved Pfizer COVID-19 vaccine in real-world use in Korea. It will follow 12,000 people who receive the vaccine as part of their normal healthcare, tracking any side effects they report for 28 days after each dose. The goal is …
Matched conditions: SARS-COV 2
Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 01, 2026 14:43 UTC
-
Stem cells touted as repair system for COVID-19 damage
Disease control TerminatedThis study aimed to test a treatment for COVID-19 using special cells called pluripotent stem cells. The idea was that these cells could act as a repair system, replacing cells damaged by the virus. The study was withdrawn and did not enroll any participants.
Matched conditions: SARS-COV 2
Phase: PHASE2 • Sponsor: DHA Coffee Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Researchers aimed to measure Pandemic's hidden mental toll
Knowledge-focused TerminatedThis study aimed to understand how the COVID-19 quarantine affected the mental health of people already receiving psychiatric care. Researchers planned to survey patients about stress, depression, and other symptoms during and after the lockdown period. The goal was to gather inf…
Matched conditions: SARS-COV 2
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Apr 04, 2026 00:05 UTC
-
Hospital tracks Staff's COVID antibodies for a year after vaccination
Knowledge-focused OngoingThis study aims to understand how the immune system responds to the AstraZeneca COVID-19 vaccine over time. Researchers are tracking 200 hospital employees who received this vaccine, measuring their antibody levels at three points over a year. The goal is to see how long vaccine …
Matched conditions: SARS-COV 2
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Pfizer digs into data: can its vaccine stop long COVID?
Knowledge-focused OngoingThis study uses existing health insurance and state vaccination records to answer two main questions. First, it aims to measure how well the Pfizer-BioNTech COVID-19 vaccine prevents Long COVID symptoms. Second, it seeks to understand the characteristics of people who are getting…
Matched conditions: SARS-COV 2
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC
-
Researchers probe heart risks after COVID shots
Knowledge-focused OngoingThis study aims to understand heart injury risks after COVID-19 vaccination. Researchers will use blood tests and heart scans to identify patients who might develop heart problems. The goal is to help doctors recognize at-risk patients earlier and determine who needs long-term mo…
Matched conditions: SARS-COV 2
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC